Panniculectomy With Umbilical Transposition in the Era of GLP-1 Receptor Agonists: The Impact of Weight Loss Modality on Post-Operative Outcomes

Clicks: 11
ID: 332425
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #104 of 125 articles by views in Aesthetic Surgery Journal Open Forum

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 125 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Panniculectomy is performed to address excess infraumbilical skin and soft tissue following weight loss. Weight loss can be achieved through lifestyle modifications, bariatric surgery, and pharmacologic therapies, such as glucagon-like peptide-1 (GLP-1) agonists. The impact of weight loss modality on post-operative outcomes remains unclear. Objectives To evaluate whether the method of weight loss influences post-operative outcomes following panniculectomy. Methods A single-center retrospective review was conducted of patients who underwent panniculectomy between 2021 and 2025. Patients were grouped into four cohorts: lifestyle modifications alone, bariatric surgery, GLP-1 agonist therapy, or combined bariatric surgery and GLP-1 agonist therapy. Patients receiving abdominoplasty with extensive undermining and rectus plication were excluded. Variables of interest included patient demographics, weight loss history, comorbidities, wound healing complications, surgical site infection, hematoma/seroma, and hospital utilization. Multivariate logistic regression was performed to analyze post-operative complications and healthcare utilization, with statistical significance set at p < 0.05. Results A total of 281 patients met inclusion criteria (lifestyle modifications: n=53 (18.9%); bariatric surgery: n=184 (65.5%); GLP-1 agonist therapy: n=20 (7.1%); and combined bariatric surgery and GLP-1 agonist therapy: n=24 (8.5%)). Multivariate analysis showed no statistically significant differences in post-operative outcomes, including wound complications, surgical site infections, seroma/hematoma, or hospital utilization. Conclusions Post-operative outcomes following panniculectomy may be similar regardless of weight loss method. Pre-operative GLP-1 agonist therapy, alone or combined with bariatric surgery, was not associated with increased post-operative complications or healthcare utilization. Our results can help guide risk stratification and decision-making for individuals pursuing panniculectomy after weight loss.
Reference Key
openalex_W7222055187 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Kasra N. Fallah, Parhom N. Towfighi, Louis Massoud, Angad S. Sidhu, Dillon Mobasser, Aniffa S Kouton, Ryan Harmelink, Nikhi Paul Singh, George S. Corpuz, Ravinder Bamba, Rachel M. Danforth, Richard Jason VonDerHaar, Mary E. Lester, Aladdin H. Hassanein, Ivan Hadad
Are you one of these authors? Claim your profile
Journal Aesthetic Surgery Journal Open Forum
Year 2026
DOI
10.1093/asjof/ojag206
URL
https://doi.org/10.1093/asjof/ojag206
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.